Ludwig Enterprises Valuation Multiples

Ludwig Enterprises Overview

About Ludwig Enterprises

Ludwig Enterprises Inc is a publicly traded Medical Technology Holding Company with Precision Genomics, Inc. and MyRNA for Life, Inc. as wholly owned subsidiaries. The company's advancements in medical technology and Artificial Intelligence (AI) have awarded it with cutting-edge genomic tools. These genomic tools have the potential to detect diseases early but also to customize treatments that may improve patient outcomes and, in some cases, even extend life. Ludwig is at the forefront of this new era with their proprietary mRNA genetic technology that has the potential to detect genetic biomarkers for inflammatory-driven diseases, including but not limited to heart disease, diabetes, preeclampsia, and cancer. It manages its business on the basis of one operating and reportable segment.

Founded

1988

HQ

Employees

3

Website

ludwigent.com

Sectors

Diagnostics & GenomicsHealth Data & AnalyticsDeepTechHealthTech

Financials (FY)

Revenue: —

EBITDA: ($1M)

EV

$8M

Valuation Multiples

Multiples.vc

Start free trial

Ludwig Enterprises Financials

Ludwig Enterprises reported last fiscal year revenue of — and negative EBITDA of ($1M).

In the same fiscal year, Ludwig Enterprises generated ($1M) in EBITDA losses and had net loss of ($2M).

Ludwig Enterprises P&L

In the most recent fiscal year, Ludwig Enterprises reported revenue of — and EBITDA of ($1M).

Ludwig Enterprises expects next 12-month revenue of XXX and NTM EBITDA of XXX

Ludwig Enterprises Stock Performance

Ludwig Enterprises has current market cap of $6M, and enterprise value of $8M.

Ludwig Enterprises' stock price is $0.03.

Ludwig Enterprises Valuation Multiples

Ludwig Enterprises trades at (6.1x) EV/EBITDA.

Ludwig Enterprises Financial Valuation Multiples

As of April 19, 2026, Ludwig Enterprises has market cap of $6M and EV of $8M.

Equity research analysts estimate Ludwig Enterprises' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Ludwig Enterprises has a P/E ratio of (2.5x).

Ludwig Enterprises Margins & Growth Rates

Ludwig Enterprises' revenue in the last fiscal year declined by (100%).

Ludwig Enterprises' revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.6M for the same period.

Ludwig Enterprises Public Comps

See public comps and valuation multiples for other Diagnostics & Genomics and Health Data & Analytics comps.

Ludwig Enterprises M&A Activity

Ludwig Enterprises acquired XXX companies to date.

Last acquisition by Ludwig Enterprises was on XXXXXXXX, XXXXX. Ludwig Enterprises acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Ludwig Enterprises Investment Activity

Ludwig Enterprises invested in XXX companies to date.

Ludwig Enterprises made its latest investment on XXXXXXXX, XXXXX. Ludwig Enterprises invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).